戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 agreement among the ECG criteria against the left ventricular mass index.
2 nt and significant determinants of the final left ventricular mass index.
3 improved, with no evidence of an increase in left ventricular mass index.
4 volume but also with significantly increased left ventricular mass index.
5    Echocardiography was used to estimate the left ventricular mass index.
6 orrelation between ventricular CT-1 mRNA and left ventricular mass index.
7 P < .001); and there was greater decrease in left ventricular mass index (-2.4 g/m(2.7) vs -1.2 g/m(2
8 ypertension did not differ significantly for left ventricular mass index (4 g/m2 [CI, - 3 to 10 g/m2)
9 were independently associated with increased left ventricular mass index (5% increase per 1-SD increa
10                                              Left ventricular mass indexed according to height at the
11                                    Increased left ventricular mass index alone did not affect accurac
12 rams and computed tomography scans to assess left ventricular mass index and coronary artery calcific
13 late human aging: age-dependent increases in left ventricular mass index and left atrial dimension, w
14                                              Left ventricular mass index and left atrial volume index
15      FGF-23 is independently associated with left ventricular mass index and left ventricular hypertr
16                                              Left ventricular mass index and relative wall thickness
17             Prespecified end points included left ventricular mass index and, in a subpopulation of p
18                  In bivariate analyses, age, left ventricular mass index, and DD grade were positivel
19 re, cholesterol, smoking, ejection fraction, left ventricular mass index, and diabetes mellitus-the e
20 nemia, sodium intake, income, fat-free mass, left ventricular mass index, and ejection fraction.
21 e in serum uric acid during follow-up, final left ventricular mass index, and final glomerular filtra
22 ted with greater disease severity, a greater left ventricular mass index, and higher hospitalization
23  the estimated GFR, a greater decline in the left-ventricular-mass index, and greater reduction in ur
24 rcise-induced wall motion abnormalities, and left ventricular mass index (beta=-0.41 [95% confidence
25 ng 20 or 40mg/kg/day showed a decline in the left ventricular mass index, compared to an increase in
26   Spironolactone induced reverse remodeling (left ventricular mass index declined; difference, -6 g/m
27                                          The left-ventricular-mass index decreased more in the low-bl
28                                          The left-ventricular-mass index decreased significantly from
29    During the study, LVH prevalence and mean left ventricular mass index did not change significantly
30                   At 48 weeks, the change in left ventricular mass index did not differ between treat
31                                      Various left ventricular mass indexes (e.g., mass indexed for he
32                                              Left ventricular mass index fell to 75% of the preoperat
33 er, in vivo MRI showed only a 3% increase in left ventricular mass indexed for body weight in mice wi
34                           The mean change in left ventricular mass index from randomization was simil
35                                          The left ventricular mass index had good discrimination for
36 ion fraction, stroke volume index, E/E', and left ventricular mass index (hazard ratio, 4.1; 95% conf
37  fraction (HR, 0.42; 95% CI, 0.20-0.89), and left ventricular mass index (HR, 1.19; 95% CI, 1.04-1.36
38 lization (OR, 9.36; 95% CI, 2.55-34.38), and left ventricular mass index (in g/m(2)) (OR, 1.02; 95% C
39                                Predictors of left ventricular mass index included systolic BP, anemia
40 ion fraction, but individual adjustments for left ventricular mass index, left atrial area, and inter
41 ressure, left ventricular ejection fraction, left ventricular mass index, left ventricular dimension,
42         Secondary end points were changes in left ventricular mass index, left ventricular ejection f
43  standard (135-140/85-90 mmHg) BP control on left ventricular mass index (LVMI) and kidney function i
44 he relationship between hematocrit (Hct) and left ventricular mass index (LVMI) and LV hypertrophy (L
45 d larger left atrial (LA) volumes and higher left ventricular mass index (LVMI) and LV mass/LV volume
46                                              Left ventricular mass index (LVMI) correlated to the sam
47            The primary outcome was change in left ventricular mass index (LVMI) measured by transthor
48 led trial evaluated the effect of EVL on the left ventricular mass index (LVMi) of 30 nondiabetic RTR
49  and obese hypertensive patients had greater left ventricular mass index (LVMI) values, but on multiv
50 ssure (SBP), heart rate (HR), pathology, and left ventricular mass index (LVMI) were measured.
51                                  We measured left ventricular mass index (LVMI) with cardiac magnetic
52 aphy and pulsed Doppler were used to measure left ventricular mass index (LVMI), cardiac index (CI),
53 line and 12-mo measures of echocardiographic left ventricular mass index (LVMI), serum C-reactive pro
54                                   The median left ventricular mass index measured with echocardiograp
55 ) had more severe aortic stenosis, increased left ventricular mass index, more myocardial injury (hig
56                   Moreover, this increase in left ventricular mass index occurs in children who have
57 on fraction of 65.5%+/-12.0% and a mean+/-SD left ventricular mass index of 66.6+/-22.3 g/m(2.7) Duri
58 week therapy with paricalcitol did not alter left ventricular mass index or improve certain measures
59 and after 12 months there was a reduction in left ventricular mass index (p < 0.03).
60 id not significantly differ in the change in left ventricular mass index (P = 0.37), left ventricular
61 tricted to the CKD subjects (11% increase in left ventricular mass index per 1-SD increase in log FGF
62 correlation with O2max (r=-0.53, P=0.003 and left ventricular mass index (r=-0.44, P=0.02).
63                                              Left ventricular mass index tended to decrease, whereas
64 ular hypertrophy was defined on the basis of left ventricular mass indexed to body surface area, heig
65  medication use, glomerular filtration rate, left ventricular mass index, wall motion abnormalities,
66  as a continuous measure, an increase in any left ventricular mass index was associated with similar
67 g the subset of participants with ALVSD, the left ventricular mass index was particularly informative
68 model was used to assess the effect of BP on left ventricular mass index, which was measured at three

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。